Stada and Xbrane Add Two To Biosimilar Development Alliance

 
• By Aidan Fry
  
Sum
Stada and Xbrane have added certolizumab and nivolumab to their existing biosimilar alliance covering ranibizumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business